is glp 1 only for diabetics The ABC's of GLP-1s: Benefits, Side Effects, and Success Stories — Nice Healthcare GLP-1 medications were first introduced

The New England Journal of Medicine, 388(11), 961963

Key factors influencing vomiting risk include: Dose escalation speed rapid increases in dose are associated with higher symptom rates Individual susceptibility some patients are inherently more prone to gastrointestinal side effects Concurrent medications other drugs affecting gastric motility may compound effects Dietary habits large, high-fat meals can exacerbate symptoms It is important to note that whilst mild, occasional vomiting can be an expected side effect, severe or persistent vomiting is not normal and may indicate complications requiring medical assessment

The EU5 public healthcare systems also reimburse GLP-1s, but often with prescribing restrictions such as specialist approval or use only as 3rd line treatment at the earliest, which limits penetration

The mechanism(s) by which GLP-1RAs would cause NAION is also unclear, particularly as GLP-1RAs are associated with neuroprotective properties and reductions in ischemic risk (96), but it has been hypothesized to be related, like the exacerbation of retinopathy, to rapid improvements in glycemic control (Figure 3)

All insulins, including Toujeo, Lantus, Tresiba, Levemir, Humalog, and NovoLog, are insulin products, not GLP-1 medications

Patches offer needle-free convenience and may improve compliance but have less long-term data